bromine has been researched along with Carcinoma 256, Walker in 9 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 9 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Blum, H; Möller, H; Pittermann, W; Pool, BL; Schmähl, D; Sinn, HJ; Spring, H; Sterz, H; Wingen, F | 1 |
Elson, LA; Ross, WC; Tisdale, MJ | 1 |
Neenan, JP; Rohde, W | 1 |
Carter, SK | 1 |
Acton, EM; Christensen, JE; Goodman, L; Keyanpour-Rad, M; Kwok, RP; Tong, HH | 1 |
Németh, L | 1 |
Baker, BR; Lourens, GJ | 2 |
Schuhmacher, J; Wesch, H; Zimmerer, J | 1 |
1 trial(s) available for bromine and Carcinoma 256, Walker
Article | Year |
---|---|
Dibromodulcitol (NSC-104800)--clinical brochure.
Topics: Animals; Antineoplastic Agents; Bromine; Carbohydrates; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Dogs; Female; Haplorhini; Humans; Leukemia L1210; Mice | 1968 |
8 other study(ies) available for bromine and Carcinoma 256, Walker
Article | Year |
---|---|
Synthesis, antitumor activity, distribution and toxicity of 4-[4-[bis(2-chloroethyl)amino]phenyl]-1-hydroxybutane-1 1-bisphosphonic acid (BAD), a new lost derivative with increased accumulation in rat osteosarcoma.
Topics: Animals; Antineoplastic Agents; Body Temperature; Body Weight; Bone and Bones; Bone Development; Bromine; Calcium; Carcinoma 256, Walker; Diphosphonates; Dose-Response Relationship, Drug; Female; Kidney; Male; Melphalan; Mice; Mice, Inbred Strains; Mutagens; Nitrogen Mustard Compounds; Osteosarcoma; Pamidronate; Radioisotopes; Rats; Rats, Inbred Strains; Salmonella typhimurium; Sex Factors; Tissue Distribution | 1986 |
Comparative antitumour and haematological effects of some bifunctional alkylating agents containing mixed functional groups.
Topics: Alkylating Agents; Animals; Blood Cell Count; Blood Cells; Bromine; Busulfan; Carcinoma 256, Walker; Ethers, Cyclic; Ethyl Ethers; Hydrolysis; Rats; Solubility; Structure-Activity Relationship; Sulfonic Acids; Water | 1973 |
Inhibition of thymidine kinase from Walker 256 carcinoma by thymidine analogs.
Topics: Animals; Bromine; Carboxylic Acids; Carcinoma 256, Walker; Chlorine; Esters; Kinetics; Thymidine; Thymidine Kinase; Thymine Nucleotides | 1973 |
Potential antitumor agents. Some 1,6-disubstituted galactitol and mannitol derivatives.
Topics: Acetals; Animals; Antineoplastic Agents; Bromine; Carcinoma 256, Walker; Chlorine; Deuterium; Fluorine; Iodine; Leukemia L1210; Magnetic Resonance Spectroscopy; Mannitol; Mice; Rats; Stereoisomerism; Sugar Alcohols; Sulfones; Sulfonic Acids; Tosyl Compounds | 1972 |
The effect of dibromodulcitol (NSC 104800) on intravenously induced cytemia of rats.
Topics: Animals; Antineoplastic Agents; Bromine; Carcinoma 256, Walker; Neoplasms, Experimental; Rats; Sugar Alcohols | 1971 |
Irreversible enzyme inhibitors. CIX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. 3.
Topics: Amides; Amines; Animals; Benzene Derivatives; Binding Sites; Bromine; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Chlorine; Columbidae; Fluorine; Folic Acid Antagonists; Leukemia L1210; Liver; Methods; Mice; Rats; Sulfonic Acids; Tetrahydrofolate Dehydrogenase; Triazines | 1968 |
Irreversible enzyme inhibitors. CX. Candidate irreversible inhibitors of dihydrofolic reductase derived from 4,6-diamino-1,2-dihydro-2,2-dimethyl-1-phenyl-s-triazine. IV.
Topics: Amides; Amines; Animals; Benzene Derivatives; Binding Sites; Bromine; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Columbidae; Folic Acid Antagonists; Leukemia L1210; Liver; Methods; Mice; Rats; Tetrahydrofolate Dehydrogenase; Triazines | 1968 |
[Marking of pyrimidine-nucleosides with 82 bromine and concentration in carcinoma Walker].
Topics: Animals; Bromine; Carcinoma 256, Walker; Chemical Phenomena; Chemistry; Injections; Nucleosides; Pyrimidines; Radiochemistry; Radioisotopes; Rats | 1971 |